The Effect of Melatonin on the Random Flap Survival in the Rat

멜라토닌이 백서의 임의형 등피판 생존에 미치는 영향

  • Hong, Seung Eun (Department of Plastic and Reconstructive Surgery, Ewha Womans University School of Medicine) ;
  • Kim, Yang Woo (Department of Plastic and Reconstructive Surgery, Ewha Womans University School of Medicine) ;
  • Burm, Jin Sik (Department of Plastic and Reconstructive Surgery, Ewha Womans University School of Medicine) ;
  • Kang, So Ra (Department of Plastic and Reconstructive Surgery, Ewha Womans University School of Medicine)
  • 홍승은 (이화여자대학교 의과대학 성형외과학교실) ;
  • 김양우 (이화여자대학교 의과대학 성형외과학교실) ;
  • 범진식 (이화여자대학교 의과대학 성형외과학교실) ;
  • 강소라 (이화여자대학교 의과대학 성형외과학교실)
  • Received : 2008.07.22
  • Accepted : 2008.09.08
  • Published : 2008.11.10

Abstract

Purpose: In skin flap surgery, surgeons often encounter distal ischemia of the flap. If a powerful free radical scavenger is used, it may reduce the formation of free radical and improves the survival of flap. Thus, the present study purposed to examine whether the survival of flap can be enhanced by administering melatonin, which is known to be a powerful free radical scavenger a antioxidant molecule. Methods: We divided 40 Sprague-Dawley rats into 4 groups, 10 in each group. For the control group(n=10), we intraperitoneally injected only carrier solution once 30 minutes before the operation, and once a day for 7 days from the day of operation. Among the experimental groups, a group(n=10) was administered with dimethyl sulfoxide(DMSO), in another group(n=10), melatonin was intraperitoneally injected, and in the other(n=10) melatonin was intraperitoneally injected and applied topically(2 cc of 1% melatonin) to the operation site. Caudally based skin flaps measuring $3{\times}10cm^2$ were elevated on the mid-dorsum of the rats. and then repositioned. On the seventh postoperative day, the survival area of the flap was measured and tissues were examined under the light microscope. Results: The control group, the DMSO group, the melatonin administration group and the melatonin administration and application group showed the mean survival rates of $55.26{\pm}9.2%$, $70.29{\pm}7.47%$, $81.45{\pm}4.14%$ and $86.1{\pm}1.52%$, respectively, for $30cm^2$ of flap. Compared to the control group, the experimental groups showed a significantly high increase in survival area at significance level of 95%. Conclusion: In this study, the survival rate of flap was enhanced through the administration of melatonin after flap surgery. This suggests that melatonin not only functions as a powerful free radical scavenger and oxygen radical scavenger but also stabilizes and protects cells, and by doing so, enhances the survival of moderately injured ischemic sites in the distal end of flap.

Keywords

References

  1. Hijjawi J, Mogford JE, Chandler LA, Cross KJ, Said H, Sosnowski BA, Mustoe TA: Platelet-derived growth factor B, but not fibroblast growth factor 2, plasmid DNA improves survival of ischemic myocutaneous flaps. Arch Surg 139: 142, 2004 https://doi.org/10.1001/archsurg.139.2.142
  2. Beyer CE, Steketee JD, Saphier D: Antioxidant properties of melatonin-an emerging mystery. Biochem Pharmacol 56: 1265, 1998 https://doi.org/10.1016/S0006-2952(98)00180-4
  3. Nordlund JJ, Lerner AB: The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocrinol Metab 45: 768, 1977 https://doi.org/10.1210/jcem-45-4-768
  4. Park HJ, Burm JS: The effect of melatonin on morphological changes of rat skeletal muscle after ischemia- reperfusion injury. J Korean Soc Plast Reconstr Surg 33: 31, 2006
  5. Reiter RJ, Tan DX, Leon J, Kilic U, Kilic E: When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med 230: 104, 2005 https://doi.org/10.1177/153537020523000205
  6. Walker PM: Pathophysiology of acute arterial occlusion. Can J Surg 29: 340, 1986
  7. Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Walden LR: Melatonin-a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann N Y Acad Sci 738: 419, 1994 https://doi.org/10.1111/j.1749-6632.1994.tb21831.x
  8. Tan DX, Poeggeler B, Reiter RJ, Chen LD, Chen S, Manchester LC, Barlow-Walden LR: The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 70: 65, 1993 https://doi.org/10.1016/0304-3835(93)90076-L
  9. Reiter RJ, Carneiro RC, Oh CS: Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res 29: 363, 1997 https://doi.org/10.1055/s-2007-979057
  10. Manson PN, Anthenelli RM, Im MJ, Bulkely GB, Hoopes JE: The role of oxygen-free radicals in ischemic tissue injury in island skin flaps. Ann Surg 198: 87, 1983 https://doi.org/10.1097/00000658-198307000-00017
  11. Fischer TW, Scholz G, Knoll B, Hipler UC, Elsner P: Melatonin suppresses reactive oxygen species in UV- irradiated leukocytes more than vitamin C and trolox. Skin Pharmacol Appl Skin Physiol 15: 367, 2002 https://doi.org/10.1159/000064543
  12. Andrabi SA, Sayeed I, Siemen D, Wolf G, Horn TF: Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 18: 869, 2004 https://doi.org/10.1096/fj.03-1031fje
  13. Carossino AM, Lombardi A, Matucci-Cerenic M, Pignone A, Cagnoni M: Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. Clin Exp Rheumatol 14: 493, 1996
  14. Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD, Saarela S: Melatonin as a free radical scavenger: implications for aging and age-related disease. Ann N Y Acad Sci 719: 1, 1994 https://doi.org/10.1111/j.1749-6632.1994.tb56817.x
  15. Bangha EP, Elsner P, Kistler GS: Suppression of UV- induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch Dermatol Res 288: 522, 1996 https://doi.org/10.1007/BF02505248